ONC today
$415.96-$4.02 (-0.96%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourExpanding
1 hourBearish
15 minBearish
5 minConsolidating
Daily trend turns down below $336.95
Key levels
Resistance$426.56
Support$392.30
Support$376.50
Latest news & SEC filings
SEC FilingBeOne Medicines Ltd. filed an insider trading report (Form 4)
AnalystRBC Capital keeps Outperform rating on BeOne Medicines, lifts target to $465
All ONC news →About BeOne Medicines
BeOne Medicines is a pharmaceutical company that develops and sells prescription medicines for cancer and other serious diseases. Its portfolio includes several oncology therapies, which are marketed to hospitals, physicians and patients. The company operates in the United States, China, Europe and other international markets, either directly or through collaborators and distributors.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
BeOne Medicines Ltd. (ONC)
What Is the Price Target for ONC?
SEPT Low Target
$340.00
SEPT Mid Target
$410.00
SEPT High Target
$459.00
Analyst Consensus
$410.00
Is ONC a Buy or Sell Right Now?
Thesis
- •Revenue growing 40.2% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ONC.
Start Free Trial →Is ONC Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$341.12
60
Moat Score
NARROW
7/9
Piotroski Score
82.1
Altman Z-Score
What Is Smart Money Doing with ONC?
Insider Signal
SELLING
0 buys / 18 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Ball Titus B. | officer | Buy | 880 | $183K | Nov 6, 2026 |
| Ball Titus B. | officer | Buy | 679 | $108K | Nov 6, 2026 |
| Ball Titus B. | officer | Sale | 1,533 | $622K | Nov 6, 2026 |
| Ball Titus B. | officer | Sale | 26 | $11K | Nov 6, 2026 |
| Wang Xiaodong | director | Buy | 31,028 | $1.1M | Oct 27, 2026 |
| Wang Xiaodong | director | Sale | 880 | $313K | Oct 27, 2026 |
| Wang Xiaodong | director | Sale | 1,440 | $512K | Oct 27, 2026 |
| Wang Xiaodong | director | Sale | 1,239 | $443K | Oct 27, 2026 |
| Wang Xiaodong | director | Sale | 1,681 | $603K | Oct 27, 2026 |
| Wang Xiaodong | director | Sale | 1,280 | $460K | Oct 27, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ONC Growth Story
Revenue YoY
40.2%
3yr Revenue CAGR
55.7%
EPS Growth YoY
140.43%
FCF Growth YoY
248.7%
Revenue Trend
STRONG
Dark Pool Trades for ONC
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ONC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:31:08 | $419.69 | 1,340 | $$562K | MIDPOINT |
| 19:03:01 | $420.62 | 1,789 | $$752K | SELL |
| 16:15:00 | $420.85 | 1,589 | $$669K | SELL |
| 16:04:30 | $420.68 | 2,131 | $$896K | BUY |
| 16:01:49 | $420.99 | 1,400 | $$589K | MIDPOINT |
5 dark pool trades shown · $$3.5M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BeOne Medicines Ltd. (ONC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ONC — frequently asked questions
What is ONC stock price today?
BeOne Medicines Ltd. (ONC) is at $415.96, down 0.96% (-$4.02) at the Nov 12, 2026 close.
Why is ONC stock moving today?
Latest ONC news — Nov 10, 2026: BeOne Medicines Ltd. filed an insider trading report (Form 4) · Nov 6, 2026: RBC Capital keeps Outperform rating on BeOne Medicines, lifts target to $465
What is the ONC price target?
The average analyst price target for ONC is $410.00, ranging from $340 to $459, based on 12 analysts. Latest: RBC Capital maintains on Oct 8, 2026.
What do analysts rate ONC?
Analyst ratings for ONC: 2 Buy, 19 Hold, 0 Sell — consensus Hold.
Did ONC beat earnings?
ONC last reported on Aug 5, 2026: EPS $2.05 vs $1.63 expected — a beat of 25.8%.
Does ONC pay a dividend?
ONC does not currently pay a dividend.
How much debt does ONC have?
BeOne Medicines Ltd. reported $789M of debt and $5.1B of cash (Jun 30, 2026).
What are ONC support and resistance levels?
Support: $392.30, $376.50, $347.61. Resistance: $426.56.
What are insiders doing with ONC?
Insider activity: SELLING, 0 buys and 18 sells in the last 90 days.
What is the latest news on ONC?
Nov 10, 2026: BeOne Medicines Ltd. filed an insider trading report (Form 4) · Nov 6, 2026: RBC Capital keeps Outperform rating on BeOne Medicines, lifts target to $465